Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that, in a final closing under a securities purchase agreement entered into on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE